POLONELLI, Luciano
 Distribuzione geografica
Continente #
NA - Nord America 10.542
EU - Europa 8.816
AS - Asia 4.114
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 9
OC - Oceania 7
Totale 23.533
Nazione #
US - Stati Uniti d'America 10.210
CN - Cina 3.103
UA - Ucraina 2.084
IE - Irlanda 1.803
DE - Germania 1.427
SE - Svezia 1.209
FI - Finlandia 1.081
IT - Italia 825
SG - Singapore 723
CA - Canada 329
TR - Turchia 194
AT - Austria 121
GB - Regno Unito 101
FR - Francia 36
BE - Belgio 34
IN - India 33
NL - Olanda 28
EU - Europa 15
JP - Giappone 15
AE - Emirati Arabi Uniti 11
ID - Indonesia 11
PL - Polonia 11
CZ - Repubblica Ceca 10
EG - Egitto 8
ES - Italia 8
RO - Romania 7
ZA - Sudafrica 6
AL - Albania 5
BR - Brasile 5
CI - Costa d'Avorio 5
HK - Hong Kong 5
HU - Ungheria 5
IL - Israele 5
AU - Australia 4
NG - Nigeria 4
LK - Sri Lanka 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RU - Federazione Russa 3
CM - Camerun 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
MX - Messico 2
MY - Malesia 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
IR - Iran 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
PR - Porto Rico 1
RS - Serbia 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
SZ - Regno dello Swaziland 1
TH - Thailandia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 23.533
Città #
Jacksonville 2.242
Dublin 1.802
Chandler 1.158
Beijing 837
Dearborn 780
Nanjing 644
Ashburn 614
Boardman 583
San Mateo 570
Princeton 504
Singapore 490
Toronto 304
Des Moines 264
Ann Arbor 245
Bremen 243
Wilmington 215
Shenyang 189
Izmir 182
Kunming 168
Nanchang 164
Hebei 160
Hefei 160
Helsinki 160
Parma 134
Vienna 121
Shanghai 106
Düsseldorf 103
Grafing 101
New York 101
Jinan 97
Santa Clara 87
Tianjin 75
Jiaxing 74
Changsha 73
Fremont 61
Seattle 57
Woodbridge 52
Guangzhou 51
Norwalk 36
Brussels 32
Houston 30
Hangzhou 28
Milan 26
Rome 24
Borås 22
Los Angeles 21
Zhengzhou 21
Chengdu 20
Dallas 17
Rockville 17
Ningbo 16
Taizhou 15
Wuhan 15
Fuzhou 13
Haikou 12
Taiyuan 12
Wenzhou 12
Nakano 11
Reggio Nell'emilia 11
Sharjah 11
Kocaeli 10
Modena 10
Munich 10
Pune 10
Washington 10
Auburn Hills 9
Redwood City 9
Shaoxing 9
Xian 9
Amsterdam 8
Catania 8
Chongqing 8
Baotou 7
Cairo 7
Edinburgh 7
Falls Church 7
London 7
Quzhou 7
Radomsko 7
Turin 7
Lugo 6
Napoli 6
Scottsdale 6
Torino 6
Abidjan 5
Bari 5
Bologna 5
Centro 5
Fairfield 5
Florence 5
Jakarta 5
Pescara 5
Piacenza 5
Redmond 5
Andover 4
Augusta 4
Brno 4
Campi Bisenzio 4
Colli Del Tronto 4
Frankfurt am Main 4
Totale 14.657
Nome #
Il problema dell’antibiogramma nelle infezioni da funghi filamentosi. 143
Antibiocorpi: Anticorpi anti-idiotipo ad attività antibiotica in vivo ed in vitro 128
Caratterizzazione ed isotipizzazione di anticorpi monoclonali murini anti-laminarina con potenziale attività candidacida. 121
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 113
Micologia Clinica. Manuale di Laboratorio. 112
L’antibiogramma per i miceti 109
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 96
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 94
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 90
Metabolic profiling of Candida albicans 90
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 89
Antifungal peptides within the antibodies 87
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 85
Antibiocorpi: anticorpi anti-idiotipo ad attività antibiotica 81
Antibody peptide based antifungal immunotherapy 81
Antibodies as a source of anti-infective peptides: an update 81
Antibody-mediated protective immunity in fungal infections 81
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 81
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 80
Oral and maxillofacial fungal infections 79
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 77
In vitro tests: how do they influence therapeutic choices? 76
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 76
Fungicidal activity of peptides encoded by immunoglobulin genes 76
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 74
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 74
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 74
A synthetic peptide as a novel anticryptococcal agent 73
Antibodies as Crypts of Antiinfective and Antitumor Peptides 73
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 73
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 73
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 73
Natural and synthetic peptides with antifungal activity 73
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 72
Involvement of beta-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin 72
Caratterizzazione dell'epitopo polisaccaridico reattivo con IgA secretorie della mannoproteina maggiore da stress secreta da Candida albicans. 72
Peptides from the inside of the antibodies are active against infectious agents and tumours 72
Conformation-sensitive Antibodies against Alzheimer Amyloid-beta by Immunization with a Thioredoxin-constrained B-cell Epitope Peptide 71
Anaerobic yeast killer system. 70
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 70
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 69
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 69
Identificazione di lieviti produttori di tossine killer in vivo 68
Antibiobodies: antibiotic internal image antibodies 68
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 68
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 68
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 67
Nuovo modello di vaccinazione idiotipica e terapia anti-idiotipica nella candidosi sistemica 66
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 66
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 66
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 66
Antifungal activity of the C-terminal peptide from human serum albumin 66
Anti-idiotypic vaccination against group B streptococci 66
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 66
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 65
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 65
A multicenter study of the in vitro activity of voriconazole against 1,996 yeast and 192 mould clinical isolates 65
Immagine interna del fenomeno killer dei lieviti 65
Metabolic profile of Candida albicans 65
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 64
Biological characterization of Fusapyrone and Deoxyfusapyrone, two bioactive secondary metabolites of Fusarium semitectum 63
Activity of nitroimidazole derivative synthetic compounds on Trichomonas vaginalis and Candida albicans isolates 63
Caratterizzazione antigenica di Microsporum canis, M. distortum, M. ferrugineum e Trichophyton soudanense. 63
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 63
Antireceptor yeast killer toxin-like antibiobodies 63
Marcatori epidemiologici. 63
Cases of imported malaria in Parma observed in the period January-September 1994 63
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 63
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 63
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 63
Anticorpi immagini interne di tossine killer 63
Antibiobodies: antibiotic-like antiidiotypic antibodies. 63
Voriconazole activity against clinical yeast isolates: a multicentre Italian study 62
Yeast killer toxins and dimorphism. 62
AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model 62
Mode of action of a killer peptide against Toxoplasma gondii 62
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 61
Attività in vitro di anticorpi anti-idiotipo di tossine killer di lieviti su microrganismi eucarioti e procarioti 61
Vaccini antiidiotipici ricombinanti attivi nei confronti di infezioni da batteri capsulati. 61
Any antibody fragment might exert antifungal activity 61
Mycobacterium parmense sp. nov 60
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 60
Meccanismi di resistenza ai farmaci antifungini. 60
Antibioantibodies: antifungal-like antiidiotipic antibodies 60
Innate antimicrobial and antiviral activities of antibody peptides 60
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 60
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 60
Protective antifungal yeast killer toxin-like antibodies 59
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 59
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants 59
Studi preliminari sul significato diagnostico di IgA secretorie adese a miceti lievitiformi nelle infezioni delle mucose 59
Secrezione di tossina killer di Pichia anomala in presenza di tunicamicina 59
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 59
Les récepteurs des toxines killer de levure 58
HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion 58
Vaccini idiotipici ed antiidiotipici 58
Production of yeast killer toxin in experimentally infected animals 58
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 58
Restriction of Influenza virus multiplication induced by PK peptide treatment 58
Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody 58
Totale 7.141
Categoria #
all - tutte 84.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.151 0 0 478 53 635 550 755 138 518 425 129 470
2020/20213.015 13 465 401 18 467 32 456 19 581 40 502 21
2021/20222.384 23 6 7 50 83 111 333 458 97 285 95 836
2022/20235.790 940 414 267 308 585 607 48 289 2.149 20 111 52
2023/20241.866 105 189 65 53 189 511 50 100 20 133 167 284
2024/20251.122 43 565 514 0 0 0 0 0 0 0 0 0
Totale 23.692